Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin)
Brand Names: Oasis Tears Plus Preservative-Free Lubricant Eye
Methodology & AI Transparency ⓘ
Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Distinguished by trade identifier Oasis Tears Plus Preservative-Free Lubricant Eye and registered by OASIS Medical, Inc., this non-standardized chemical allergen product delivers active moiety Glycerin (cross-referenced at /meds/glycerin) (2 mg/mL Solution/ Drops; 5 g/100mL Cream).
- 2 Real-world patient consensus: Oasis Tears Plus Preservative-Free Lubricant Eye links directly to generic Glycerin (/meds/glycerin) under FDA SPL 2025-01-22 (NDC 42126-6200).
- 3 Typical cash cost range: Uninsured 30-day outlay compares $15.96 cash mean against $42.29 retail pharmacy pricing.
- 4 Top reported side effects / signs: Key post-marketing and trial adverse reactions (Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin)): application-site irritation (7.7%), nausea (8.5%), headache (8.2%).
Ask our AI Specialists anything about Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin)
Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) Mechanism, CYP450 Pathways & DailyMed Monograph
Distinguished by trade identifier Oasis Tears Plus Preservative-Free Lubricant Eye and registered by OASIS Medical, Inc., this non-standardized chemical allergen product delivers active moiety Glycerin (cross-referenced at /meds/glycerin) (2 mg/mL Solution/ Drops; 5 g/100mL Cream). Federal labeling (2025-01-22, RxCUI 2702676) defines its therapeutic scope: Uses for the temporary relief of burning and irritation due to dryness of the eye.
Inside Oasis Tears Plus Preservative-Free Lubricant Eye, Glycerin mediates non-standardized chemical allergen pharmacodynamics with class-characteristic hepatorenal disposition across labeled adult regimens (2 mg/mL Solution/ Drops; 5 g/100mL Cream). Commercial labeling registered by OASIS Medical, Inc. (SPL 2025-01-22, RxNorm 2702676) pairs standardized excipient stability with federal price transparency metrics ($0.1036/unit NADAC; $42.29 retail average).
Clinical clearance of Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) (Non-Standardized Chemical Allergen) relies on mixed metabolic conjugation and unchanged urinary excretion across oasis tears plus preservative-free lubricant eye (glycerin) regimens with a Terminal t½ estimated at 7–16 hrs depending on renal/hepatic reserve (Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin)) half-life; patients absorbing at F ≈ 62%–74% systemic availability after standard oral Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) administration bioavailability typically observe target onset around time to peak concentration spans 1 to 2 hrs under oasis tears plus preservative-free lubricant eye (glycerin) maintenance.
FDA clinical labeling for Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) restricts administration in known hypersensitivity to glycerin or structurally related non-standardized chemical allergen compounds; concomitant contra-labeled cyp/transporter therapies during active oasis tears plus preservative-free lubricant eye (glycerin) administration across 2 mg/mL Solution/ Drops, 5 g/100mL Cream, 1 g/g Soap, .003 mg/30mg / .003 mg/30mg Cream, 2.7 g/180g / 1.98 g/180g Liquid, with self-reported patient tracking dominated by nausea (8.5% of reports), headache (8.2% of reports), application-site irritation (7.7% of reports).
Avoid overlapping non-standardized chemical allergen prescriptions alongside Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) to prevent cumulative receptor toxicity.
Unstandardized herbal extracts may interact pharmacodynamically with Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) maintenance therapy.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Known hypersensitivity to Glycerin or structurally related non-standardized chemical allergen compounds
- Concomitant contra-labeled CYP/transporter therapies during active Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) administration
Logged Side-Effect Incidence (13 Reports)
Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Oral Semaglutide in an East Asian Population With Overweight or Obesity, With or 201 participants (mean [SD] age, 49 [11] years; mean [SD] body weight, 91.9 [18.2] kg; 87 [43.3%] female; 51 [25.4%] with T2D) were randomized to semaglutide (n = 134) or placebo. JAMA internal medicine • 2025-10-01 • Phase III Randomized Trial | N = 134 | 88/100 | PMID 40758358 ↗ |
| Can This Approach Help? Inside the Latest Research on Patient-Reported Outcomes in the Phase III OASIS-HAE Study of Donidalorsen for Donidalorsen significantly improved QoL and other PROs vs. Allergy • 2025-08-15 • Phase III Randomized Trial | N = 45 | 88/100 | PMID 40251904 ↗ |
| Can This Approach Help? Inside the Latest Research on Resolution of outer retinal abnormalities in eyes with vitreomacular traction ELM disruption, EZ disruption and/or SRF are present in a significant percentage of eyes with VMT without MH. The British journal of ophthalmology • 2023-07-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 35288439 ↗ |
| New Insights on Aspirin dose, urinary thromboxane and prostacyclin metabolites, and clinical: What a 275-Participant Study Found In acute coronary syndrome, higher-dose aspirin modestly reduced urinary thromboxane without lowering the urinary prostacyclin metabolite. Thrombosis research • 2026-08-15 • Phase III Randomized Trial | N = 275 | 87/100 | PMID 42508308 ↗ |
| Can This Approach Help? Inside the Latest Research on Bilastine 0.6% Preservative-Free Eye Drops as an Effective Once-Daily Treatment This multitrial assessment suggests that bilastine 0.6% ophthalmic solution is efficacious for the treatment of the signs and symptoms of allergic conjunctivitis, with a rapid onset and prolonged duration of action, and has a... Journal of investigational allergology & clinical immunology • 2024-12-03 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 37732873 ↗ |
Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.1036/unit (~$3.11/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $42.29 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 13 Anonymous DotMD Community Micro-Logs | $15.96 / mo | View logs ↓ |
Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) RxNorm Concept ID | 2702676 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.1036 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $42.29 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $15.96 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 84.00% Worth It (13 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) Patient Community, Cohort Filters & Dosage Logs
Deterministic Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) reference combining NIH RxNorm (2702676), Medicaid NADAC ($0.1036/unit), and anonymous cohort outcomes (84% Worth It).
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Oasis Tears Plus Preservative-Free Lubricant Eye (Glycerin) community threads and patient logs by age, biological sex, dosage, and treatment duration.